Drug details
Bosulif (bosutinib tablets)
type of Antineoplastic Tyrosine Kinase Inhibitors
Bosulif (bosutinib) is a kinase inhibitor used to treat adult patients with chronic accelerated or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance or intolerance to prior therapy.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- upper stomach pain,
- loss of appetite,
- itching,
- dark urine,
- vomiting,
- diarrhea,
- fever,
- easy bruising,
- unusual bleeding,
- pale skin,
- lightheadedness,
- shortness of breath,
- cold hands and feet,
- chills,
- tiredness,
- stomach pain,
- clay-colored stools,
- yellowing of the skin or eyes (jaundice),
- dizziness,
- joint pain,
- back pain,
- wheezing,
- flu-like symptoms,
- sweating,
- mouth sores,
- chest pain, and
- swelling in your hands or feet,
- rapid weight gain,
- anxiety,
- pain when you breathe,
- skin sores,
- severe or ongoing nausea,
- blood in your stools,
- urinating more or less than usual,
- gasping for breath,
- cough with foamy mucus,
- fast or uneven heart rate
The following drugs are related to Bosulif, either as a replacement or used together:
- Asparlas (calaspargase pegol-mknl injection)
- Belrapzo (bendamustine hydrochloride injection)
- Cerubidine (daunorubicin)
- Leustatin (cladribine injection for intravenous infusion only)
- Sprycel (dasatinib)
- Fludara (fludarabine)
- Mylotarg (gemtuzumab ozogamicin for injection)
- Gleevec (imatinib mesylate)
- Idamycin (idarubicin)
- Idamycin PFS (idarubicin hydrochloride injection)
- Tibsovo (ivosidenib tablets)
- Purinethol (mercaptopurine)
- Tasigna Capsules (nilotinib capsules)